This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2 Jun 2013

Pathway analysis may trigger new therapies to target rheumatoid arthritis

Scientists have made a discovery that could lead to new therapies for rheumatoid arthritis

Pathway analysis carried out by US researchers could be used to identify novel therapeutic targets to treat rheumatoid arthritis, according to a study published in the journal Genome Medicine.

Related News